.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Teva
US Department of Justice
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
Fish and Richardson
Farmers Insurance
Moodys
Novartis

Generated: June 26, 2017

DrugPatentWatch Database Preview

Ibuprofen; pseudoephedrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ibuprofen; pseudoephedrine hydrochloride and what is the scope of ibuprofen; pseudoephedrine hydrochloride patent protection?

Ibuprofen; pseudoephedrine hydrochloride
is the generic ingredient in six branded drugs marketed by J And J Consumer Inc, Dr Reddys Labs Ltd, Ohm Labs, Pfizer, Perrigo, and Contract Pharmacal, and is included in nine NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ibuprofen; pseudoephedrine hydrochloride has fourteen patent family members in thirteen countries.

There are sixty-three drug master file entries for ibuprofen; pseudoephedrine hydrochloride. Thirty-one suppliers are listed for this compound.

Summary for Generic Name: ibuprofen; pseudoephedrine hydrochloride

Tradenames:6
Patents:2
Applicants:6
NDAs:9
Drug Master File Entries: see list63
Suppliers / Packagers: see list31
Clinical Trials: see list2,765
Drug Prices:see low prices
DailyMed Link:ibuprofen; pseudoephedrine hydrochloride at DailyMed

Pharmacology for Ingredient: ibuprofen; pseudoephedrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ohm Labs
IBUPROHM COLD AND SINUS
ibuprofen; pseudoephedrine hydrochloride
TABLET;ORAL074567-001Apr 17, 2001OTCNoNo► Subscribe► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN COLD
ibuprofen; pseudoephedrine hydrochloride
SUSPENSION;ORAL021128-001Aug 1, 2000OTCYesYes6,211,246► Subscribe ► Subscribe
Pfizer
ADVIL COLD AND SINUS
ibuprofen; pseudoephedrine hydrochloride
CAPSULE;ORAL021374-001May 30, 2002OTCYesYes► Subscribe► Subscribe
J And J Consumer Inc
SINE-AID IB
ibuprofen; pseudoephedrine hydrochloride
TABLET;ORAL019899-001Dec 31, 1992OTCNoNo► Subscribe► Subscribe
Contract Pharmacal
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
ibuprofen; pseudoephedrine hydrochloride
TABLET;ORAL075588-001Apr 8, 2002OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ibuprofen; pseudoephedrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
ADVIL COLD AND SINUS
ibuprofen; pseudoephedrine hydrochloride
TABLET;ORAL019771-001Sep 19, 19894,552,899*PED► Subscribe
Pfizer
ADVIL COLD AND SINUS
ibuprofen; pseudoephedrine hydrochloride
CAPSULE;ORAL021374-001May 30, 20025,360,615*PED► Subscribe
Pfizer
ADVIL COLD AND SINUS
ibuprofen; pseudoephedrine hydrochloride
CAPSULE;ORAL021374-001May 30, 20025,071,643*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: ibuprofen; pseudoephedrine hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,060,730Rapidly absorbed liquid compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ibuprofen; pseudoephedrine hydrochloride

Country Document Number Estimated Expiration
Spain2397262► Subscribe
Brazil0002607► Subscribe
Argentina024314► Subscribe
China1277841► Subscribe
Japan2001019638► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Novartis
AstraZeneca
Fish and Richardson
Covington
Accenture
Merck
Moodys
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot